Updated Jul 16, 2026 · Last SEC filing 2026-06-08
Turn Therapeutics Inc. (TTRX) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-08. 7 Form 8-K material event filings were reported by TTRX in the last 90 days. InsiderAlpha tracks every TTRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0002023016 |
| Form 4 filings (90d) | 5 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Latest Form 4 filing | 2026-06-08 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Burnam Bradley Evan | Chief Executive Officer | G — Bona-fide gift | 300.0K | $0.00 | — | SEC | |
| Burnam Bradley Evan | Chief Executive Officer | G — Bona-fide gift | 300.0K | $0.00 | — | SEC | |
| Burnam Bradley Evan | Chief Executive Officer | G — Bona-fide gift | 300.0K | $0.00 | — | SEC | |
| Burnam Bradley Evan | Chief Executive Officer | G — Bona-fide gift | 300.0K | $0.00 | — | SEC | |
| Burnam Bradley Evan | Chief Executive Officer | G — Bona-fide gift | 300.0K | $0.00 | — | SEC | |
| GOLDEN ARTHUR F | Director | G — Bona-fide gift | 300.0K | $0.00 | — | SEC | |
| Dewhurst Martin William | Director | A — Grant or award | 21.9K | $0.00 | — | SEC | |
| Chaudhary Zuraiz | See Remarks | P — Open-market purchase | 2.5K | $3.50 | $9K | SEC | |
| GOLDEN ARTHUR F | Director | P — Open-market purchase | 9.9K | $3.44 | $34K | SEC | |
| GOLDEN ARTHUR F | Director | P — Open-market purchase | 20.5K | $2.87 | $59K | SEC | |
| Chaudhary Zuraiz | See Remarks | P — Open-market purchase | 1.0K | $3.29 | $3K | SEC | |
| Chaudhary Zuraiz | See Remarks | P — Open-market purchase | 1.4K | $2.61 | $4K | SEC | |
| Chaudhary Zuraiz | See Remarks | P — Open-market purchase | 2.5K | $3.62 | $9K | SEC | |
| Gengos Andrew | Director | A — Grant or award | 10.0K | $0.00 | — | SEC | |
| Ghodadra Neilesh Shailesh | Chief Medical Officer | A — Grant or award | 10.0K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Turn Therapeutics Inc. (TTRX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Burnam Bradley Evan | 4 | — |
| GOLDEN ARTHUR F | 1 | — |
| Gengos Andrew | 1 | — |
| Kester Kent Edward | 1 | — |
| Dewhurst Martin William | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TTRX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TTRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.